No. | At presentation | Follow-up | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AP deficiency | GH (ng/mL, <2.5) | IGF1 (ng/mL, 74–388) | ACTH (pg/mL, 0–46) | Cortisol (μg/dL, 4–25) | LH (IU/L, 1.2–58.64) | FSH (IU/L, 1.27–113.59) | PRL (ng/mL, 2.74–26.72) | E2 (pg/mL, 20–273) | T (ng/dL, 0.1–7.8) | TSH (μIU/mL,0.38–4.34) | FT4 (ng/dL,0.81–1.89) | AP deficiency | |
1 | Panhypopituitary | 0.2 | 25 | 15.29 | 0.81 | 0 | 0.2 | 15.84 | 10.4 | 11.2 | 0.202 | 0.56 | Panhypopituitary |
2 | Not impaired | 0.5 | 129 | 28. 6 | 13.51 | 3.12 | 4.91 | 37.1 | 44 | 0.19 | 1.54 | 1.22 | Not impaired |
3 | GH, LH-FSH deficiency | <0.05 | 72 | 26.3 | 12.05 | 0.43 | 0.36 | 17.39 | 25 | <0.1 | 8.485 | 1.01 | Panhypopituitary |
4 | Not impaired | 1.4 | 198 | 30.6 | 12.9 | 2.63 | 1.0 | 15.6 | 11.8 | 360.8 | 2.662 | 1.380 | NA |
5 | Panhypopituitary | <0.05 | 44 | 7.6 | 0.74 | 0 | 0.3 | 11.7 | 10.2 | 5.2 | 2.539 | 0.60 | Panhypopituitary |
6 | Not impaired | 0.2 | 381 | 51.3 | 13.65 | 4.7 | 4.42 | 18.14 | 56 | 2.11 | 2.581 | 1.333 | Not impaired |
7 | Panhypopituitary | 0.12 | 68 | 7.6 | 0.2 | 5.2 | 1.67 | 51.22 | 0.09 | 0.73 | 0.26 | 0.77 | Panhypopituitary |